| Business Summary | | Caremark
Rx,
Inc.
is
one
of
the
largest
pharmaceutical
services
companies
in
the
United
States,
with
net
revenue
of
approximately
$4.4
billion
for
2000.
The
Company's
operations
are
conducted
through
its
wholly
owned
subsidiary
Caremark
Inc.,
which
assists
employers,
insurance
companies,
unions,
government
employee
groups,
managed
care
organizations
and
other
sponsors
of
health
benefit
plans
and
individuals
throughout
the
United
States
in
delivering
prescription
drugs
in
a
cost-effective
manner.
During
the
year
ended
December
31,
2000,
the
Company
managed
over
68
million
prescriptions
for
individuals
from
over
1,200
organizations. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Caremark
Rx,
Inc.
provides
pharmacy
benefit
management
services
and
therapeutic
pharmaceutical
services.
For
the
six
months
ended
6/30/01,
net
revenues
rose
29%
to
$2.75
billion.
Net
income
from
continuing
operations
applicable
to
Common
totalled
$74.3
million,
up
from
$35.8
million.
Revenues
benefited
from
new
customer
contracts
and
growth
in
pharmacy
claims
processed.
Net
income
also
reflects
lower
interest
expense
attributable
to
the
retirement
of
senior
notes. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Edwin Crawford, 52 Chairman,
CEO | $1.4M | -- | James Dickerson, Jr., 54 Pres,
COO, Director | 1.2M | $3.2M | C. Piccolo, 60 Vice
Chairman | -- | -- | Howard McLure, 43 CFO,
Exec. VP | -- | -- | John Arlotta, 51 Pres
-- Caremark Pharmaceutical Group | 1.2M | -- | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|